AI in Action E150: David Ruau, VP, Head of Global Data Assets & Decision Science at Bayer Pharmaceuticals

,  | November 20 2020 | Mark Kelly

Welcome to episode 150 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.

Today’s guest is David Ruau, VP, Head of Global Data Assets and Decision Science at Bayer Pharmaceuticals. David is an experienced digital business leader in the life-science industry with over ten years of experience in integrative bioinformatics and biomedical research. David joined Bayer in 2017 and currently leads the data asset and data science team working across all functions at Bayer Pharmaceuticals.

Bayer is a global enterprise with core competencies in the Life Science fields of healthcare and agriculture. Bayer’s products help address some of today’s biggest challenges, including global population growth, an ageing society and the need to make efficient and sustainable use of natural resources. Their mission is to improve people’s quality of life by preventing, alleviating or curing diseases. 

In the episode, David will discuss: 

The fascinating work he is doing with Bayer 

What attracted to the pharma and life sciences industry 

How to build a successful Data Science team 

Key Data Science skills needed for a career in the pharma sector 

Introducing a digital transformation in your organisation 

If you would like to find out more about David and the work at Bayer Pharmaceuticals, check out the website pharma.bayer.com or follow them on Twitter @BayerPharma. You can also connect with David on Linkedin or follow him on Twitter @druau

What did you make of David’s podcast? Where do you see the future of Artificial Intelligence in the Life Sciences industry heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.

Subscribe to The Alldus Podcast:

Welcome to episode 150 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.

Today’s guest is David Ruau, VP, Head of Global Data Assets and Decision Science at Bayer Pharmaceuticals. David is an experienced digital business leader in the life-science industry with over ten years of experience in integrative bioinformatics and biomedical research. David joined Bayer in 2017 and currently leads the data asset and data science team working across all functions at Bayer Pharmaceuticals.

Bayer is a global enterprise with core competencies in the Life Science fields of healthcare and agriculture. Bayer’s products help address some of today’s biggest challenges, including global population growth, an ageing society and the need to make efficient and sustainable use of natural resources. Their mission is to improve people’s quality of life by preventing, alleviating or curing diseases. 

In the episode, David will discuss: 

The fascinating work he is doing with Bayer 

What attracted to the pharma and life sciences industry 

How to build a successful Data Science team 

Key Data Science skills needed for a career in the pharma sector 

Introducing a digital transformation in your organisation 

If you would like to find out more about David and the work at Bayer Pharmaceuticals, check out the website pharma.bayer.com or follow them on Twitter @BayerPharma. You can also connect with David on Linkedin or follow him on Twitter @druau

What did you make of David’s podcast? Where do you see the future of Artificial Intelligence in the Life Sciences industry heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.

Subscribe to The Alldus Podcast:

related podcasts

ServiceNow Series E88: John Cullom, CEO at Northcraft Analytics

 Welcome to episode 88 in our Digital Transformation series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being…

Read More

AI in Action E418: Gretchen Stewart, Chief Data Scientist at Intel’s Public Sector

 Welcome to episode 418 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives. Powered by Alldus International, our goal is to share with you the insights of technologists and data science…

Read More

AI in Action E417: Su Huang, Head of Data Strategy at Datavant

Su Huang, Head of Data Strategy at Datavant joins host JP Valentine on the AI in Action USA podcast to discuss the challenges of data exchange in the healthcare industry, how Datavant’s platform is positively impacting the Healthcare sector, her top advice to aspiring data scientists & much more

Read More